Page last updated: 2024-09-03

morphiceptin and u 69593

morphiceptin has been researched along with u 69593 in 1 studies

Compound Research Comparison

Studies
(morphiceptin)
Trials
(morphiceptin)
Recent Studies (post-2010)
(morphiceptin)
Studies
(u 69593)
Trials
(u 69593)
Recent Studies (post-2010) (u 69593)
139012524075

Protein Interaction Comparison

ProteinTaxonomymorphiceptin (IC50)u 69593 (IC50)
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0006
Mu-type opioid receptorHomo sapiens (human)0.194
Delta-type opioid receptorHomo sapiens (human)3.6437
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0021
Kappa-type opioid receptorHomo sapiens (human)0.058
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.588

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dawson, G; Dawson, SA; Goswami, R1

Other Studies

1 other study(ies) available for morphiceptin and u 69593

ArticleYear
Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons.
    Journal of neurochemistry, 1998, Volume: 70, Issue:4

    Topics: Androstadienes; Animals; Apoptosis; Benzeneacetamides; Cell Line; Cell Survival; Chick Embryo; Cyclic AMP; Endorphins; Enzyme Inhibitors; Mice; Narcotics; Neurons; Pyrrolidines; Receptors, Opioid, kappa; Staurosporine; Wortmannin

1998